Search For "active pharmaceutical ingredients"
Jubilant Pharma ratings unaffected by proposed reorganisation: Fit
Updated : 4 months ago IST
Mumbai (Maharashtra) [India], July 30 (ANI): The proposed transfer of Jubilant Pharma Ltd's (JPL's) active pharmaceutical ingredients (API) business to its parent Jubilant Pharmova Ltd (JPHL) will not affect JPL's ratings, says Fitch Ratings.
Read More
Govt waives import duty on Remdesivir API, injections and specific
Updated : 7 months, 2 weeks ago IST
New Delhi [India], April 21 (ANI): The import of Remdesivir Active Pharmaceutical Ingredients (API), injections and specific inputs have been made import duty free till October 31 amid the ongoing surge in COVID-19 cases in the country.
Read More
Centre prohibits exports of Remdesivir till COVID-19 situation in
Updated : 7 months, 3 weeks ago IST
New Delhi [India]. April 11 (ANI): The Centre on Sunday prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the Covid-19 situation in the country improves.
Read More
Morepen labs eyeing multi-billion dollar global market for New API
Updated : 9 months, 3 weeks ago IST
New Delhi [India], February 12 (ANI/NewsVoir): Morepen Laboratories Ltd. is eyeing an all-new multi-billion dollar global API (Active Pharmaceutical Ingredients) market with the addition of new molecules in its bulk drugs portfolio. The focus areas of these new molecules include chronic and
Read More
India's incentives for domestic API production could cut supply ri
Updated : 1 year, 3 months ago IST
Mumbai (Maharashtra) [India], Aug 10 (ANI): The Indian government's recent incentives to boost domestic manufacturing of active pharmaceutical ingredients (APIs) and key starting materials (KSMs) can improve backward integration over the next few years and curtail supply-chain disruption ris
Read More
Indian pharma compliance standards improving, regulatory risks her
Updated : 1 year, 4 months ago IST
Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said o
Read More
Centre removes restrictions on exports of paracetamol APIs
Updated : 1 year, 6 months ago IST
New Delhi [India], May 29 (ANI): The Central government on Thursday removed restrictions on the export of paracetamol APIs (active pharmaceutical ingredients) making it export free.
Read More
Govt removes export restrictions on 12 APIs
Updated : 1 year, 7 months ago IST
New Delhi [India], April 7 (ANI): The Central government has removed restrictions on the export of 12 Active Pharmaceutical Ingredients (APIs) and their formulations, the Union Commerce and Industry Ministry said on Monday.
Read More
Coronavirus: No shortage of APIs, formulations, says NPPA
Updated : 1 year, 8 months ago IST
New Delhi [India], Mar 14 (ANI): The National Pharmaceutical Pricing Authority (NPPA) on Friday said that they have not received any reference regarding the shortage of active pharmaceutical ingredients (APIs) and formulations.
Read More
Coronavirus: Restrictions imposed on some APIs, says Union Ministe
Updated : 1 year, 9 months ago IST
Gandhinagar (Gujarat) [India], Mar 6 (ANI): Union Minister of State for Shipping, and Chemical and Fertilizers, Mansukh Mandaviya has said that the government has imposed short term restrictions on some active pharmaceutical ingredients (API) with regards to coronavirus preparedness.
Read More
Amid coronavirus scare, India restricts export of 26 Active Pharma
Updated : 1 year, 9 months ago IST
New Delhi [India], Mar 3 (ANI): Amid coronavirus outbreak, the Directorate General of Foreign Trade (DGFT) has decided to restrict export of 26 Active Pharmaceutical Ingredients (API) in its revised export policy, due to concerns on the shortage of medicine in domestic markets.
Read More
Ind-Ra withdraws CP rating for Dishman Carbogen Amics, places it o
Updated : 1 year, 11 months ago IST
Mumbai (Maharashtra) [India], Jan 1 (ANI): India Ratings and Research (Ind-Ra) has placed Dishman Carbogen Amcis Ltd's (DCAL's) long-term issuer rating of A-plus on rating watch evolving (RWE).
Read More